Experiencing slow enrollment in your study? Considering a hybrid approach? Beware of common misconceptions about the design and execution of DCTs and engage with experts with real-world experience. At UBC, we understand the importance of debunking DCT mythologies and authentically address key considerations necessary to execute a successful hybrid study design strategy. Learn how UBC can help https://hubs.li/Q02KtXtF0 #PatientsFirst #DCT #Pharma #RWE
UBC
Pharmaceutical Manufacturing
Blue Bell, PA 29,063 followers
Patients First. Powered by Evidence.
About us
United BioSource LLC (UBC) is the leading provider of evidence development solutions with expertise in uniting evidence and access. UBC helps biopharma mitigate risk, address product hurdles, and demonstrate safety, efficacy, and value under real-world conditions. Underpinned by our scientific expertise, data and analytics, and innovative technologies, we offer our customers flexible solutions generating the relevant real-world data necessary to make more informed decisions earlier, meet stakeholder requirements, and ultimately, drive better patient outcomes.
- Website
-
http://www.ubc.com
External link for UBC
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Blue Bell, PA
- Type
- Privately Held
- Founded
- 2003
- Specialties
- Evidence Development, Modernized Study Design & Execution, Late-Stage Research, Risk Evaluation & Mitigation Strategies, Pharmacovigilance, Patient Access & Hub Services, Reimbursement & Patient Assistant Programs, and Nursing & Adherence
Locations
Employees at UBC
-
Timothy DiChiara, PhD
Principal Medical Writer
-
Radhika Rao
Senior Project Manager & Service Delivery Expert | Champion in Vendor Performance Oversight | IT Transformation Specialist | Strategic Leader
-
Rebecca Richardson
GQC CAPA administrator at UBC
-
Troy Mann
Manager - Program Management at UBC
Updates
-
Meet Cecilia Fantini, UBC Pharmacovigilance (PV) Process Excellence Manager. Mrs. Fantini has 12 years’ experience in PV and joined UBC to support clients in the authoring, reviewing and management of EU and UK PV System Master Files and Summary of PV Systems, working closely with EU and UK QPPVs. Read her full bio: https://hubs.ly/Q02Kh2Bf0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety
-
-
Register for our August 27 webinar to learn how UBC and SymetryML can help you enhance your observational research model by leveraging an AI-driven virtual evidence platform. Click here to register https://hubs.li/Q02KfNQN0 #PatientsFirst #RWE #RWD #EvidenceGeneration #FierceBiotech
-
-
To optimize your therapeutic's launch, it is critical to deftly navigate FDA negotiations and IT builds around REMS. Find out more from Director of REMS Operations Natalie Eiland at https://hubs.ly/Q02Khp7B0 #PatientsFirst #REMS #PatientSafety #Pharma
-
-
If you haven’t considered an RWD study to assess drug safety, find out how regulatory bodies are encouraging this approach with a recent guidance at https://hubs.li/Q02JcN1P0 #PatientsFirst #FDA #Pharma #RWD
-
-
Starting with the first REMS, UBC has implemented over 120 REMS programs throughout the last decade. We’ve learned a few lessons, so you don’t have to. Read our “Lessons Learned When Implementing a REMS” white paper. Download here: https://hubs.li/Q02JDpRy0 #PatientsFirst #REMS #SafetyandRiskManagement #PatientSafety
-
-
Want to learn the truth about so called “decentralized trials?” Bypass the marketing jargon and speak to our experts with firsthand experience implementing these trial designs. At UBC, we design and execute modernized studies that leverage technologically advanced data acquisition solutions. Learn how UBC can help https://lnkd.in/eb-jh9eN #PatientsFirst #DCT #Pharma #RWE
-
Regulatory bodies continue to affirm standards and use cases for utilizing RWD and RWE in submissions. Read an update on the latest guidance at https://hubs.li/Q02JcNkw0 #PatientsFirst #FDA #RWD #PatientSafety
-
-
Need to enhance your safety oversight? UBC has leading PV solutions and decades of PV system migration experience to reduce the complexities of change. Learn about our process and best practices. https://hubs.li/Q02JngFC0 #PatientsFirst #Pharmacovigilance #SafetyandRiskManagement #PatientSafety
-
-
Today is the final day of the REMS Innovation Summit! If you missed our team in-person, learn more about UBC's best-in-class REMS solutions or get in touch with our team virtually at https://hubs.li/Q02FFpVM0 #PatientsFirst #REMS #REMSSummit #Pharma
-